Tools
Tools
Dehnavi, S, Sadeghi, M, Penson, P, Banach, M, Jamialahmadi, T and Sahebkar, A (2019) The Role of Protein SUMOylation in the Pathogenesis of Atherosclerosis. Journal of Clinical Medicine, 8 (11). ISSN 2077-0383
|
Text
The Role of Protein SUMOylation in the Pathogenesis of Atherosclerosis.pdf - Published Version Available under License Creative Commons Attribution. Download (388kB) | Preview |
Abstract
Atherosclerosis is a progressive, inflammatory cardiovascular disorder characterized by the development of lipid-filled plaques within arteries. Endothelial cell dysfunction in the walls of blood vessels results in an increase in vascular permeability, alteration of the components of the extracellular matrix, and retention of LDL in the sub-endothelial space, thereby accelerating plaque formation. Epigenetic modification by SUMOylation can influence the surface interactions of target proteins and affect cellular functionality, thereby regulating multiple cellular processes. Small ubiquitin-like modifier (SUMO) can modulate NFκB and other proteins such as p53, KLF, and ERK5, which have critical roles in atherogenesis. Furthermore, SUMO regulates leukocyte recruitment and cytokine release and the expression of adherence molecules. In this review, we discuss the regulation by SUMO and SUMOylation modifications of proteins and pathways involved in atherosclerosis.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | 1103 Clinical Sciences |
| Subjects: | R Medicine > RM Therapeutics. Pharmacology |
| Divisions: | Pharmacy & Biomolecular Sciences |
| Publisher: | MDPI AG |
| Date Deposited: | 06 Nov 2019 11:52 |
| Last Modified: | 04 Sep 2021 08:31 |
| DOI or ID number: | 10.3390/jcm8111856 |
| URI: | https://researchonline.ljmu.ac.uk/id/eprint/11712 |
 |
View Item |